Technical Analysis for BLCO - Bausch + Lomb Corporation
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Bollinger Band Squeeze | Range Contraction | 0.00% | |
Lower Bollinger Band Walk | Weakness | 0.00% | |
BB Squeeze + Lower Band Touch | Range Contraction | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
50 DMA Resistance | Bearish | 0.48% | |
Bollinger Band Squeeze | Range Contraction | 0.48% | |
Stochastic Reached Oversold | Weakness | 0.48% | |
BB Squeeze + Lower Band Touch | Range Contraction | 0.48% |
Alert | Time |
---|---|
Up 1% | about 9 hours ago |
60 Minute Opening Range Breakdown | 3 days ago |
Rose Above Previous Day's High | 3 days ago |
50 DMA Resistance | 3 days ago |
10 DMA Resistance | 3 days ago |
Get a Trading Assistant
- Earnings date: 07/31/2024
Bausch + Lomb Corporation Description
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. Its Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation is a subsidiary of Bausch Health Companies Inc.
Classification
Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Ophthalmology Glaucoma Vision Cataracts Surgical Specialties Treatment Of Glaucoma Contact Lenses Cataract Surgery Retinal Diseases Conjunctivitis Lens Care Products Ocular Hypertension Generic Pharmaceutical Products
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 21.2299 |
52 Week Low | 13.16 |
Average Volume | 417,518 |
200-Day Moving Average | 15.64 |
50-Day Moving Average | 14.87 |
20-Day Moving Average | 14.99 |
10-Day Moving Average | 14.82 |
Average True Range | 0.39 |
RSI (14) | 41.86 |
ADX | 10.12 |
+DI | 13.42 |
-DI | 20.21 |
Chandelier Exit (Long, 3 ATRs) | 14.55 |
Chandelier Exit (Short, 3 ATRs) | 15.58 |
Upper Bollinger Bands | 15.52 |
Lower Bollinger Band | 14.47 |
Percent B (%b) | 0.12 |
BandWidth | 7.03 |
MACD Line | -0.10 |
MACD Signal Line | -0.04 |
MACD Histogram | -0.0539 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 15.13 | ||||
Resistance 3 (R3) | 15.14 | 14.96 | 15.04 | ||
Resistance 2 (R2) | 14.96 | 14.83 | 14.96 | 15.01 | |
Resistance 1 (R1) | 14.78 | 14.74 | 14.87 | 14.77 | 14.98 |
Pivot Point | 14.60 | 14.60 | 14.65 | 14.60 | 14.60 |
Support 1 (S1) | 14.42 | 14.47 | 14.51 | 14.41 | 14.20 |
Support 2 (S2) | 14.24 | 14.38 | 14.24 | 14.17 | |
Support 3 (S3) | 14.06 | 14.24 | 14.14 | ||
Support 4 (S4) | 14.05 |